Sarah Guo, founder of the AI-focused VC firm Conviction and co-host of the No Priors podcast (which has a YouTube channel with over 50K subscribers) at NVIDIA GTC 2026 . From rece ...

Backed Financing Following Extensive Diligence UNIONDALE, NY, March 17, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and ...

This clinical-stage biotech develops antibody therapies targeting autoimmune diseases, with a lead candidate in Phase II trials.

A new Ohio poll shows Democrat Amy Acton leading Republican Vivek Ramaswamy 53%–43% in the 2026 governor’s race, marking a ...

CNN will debut a new original series, Wants To Live Forever, at 9 p.m. ET/PT on April 11. The six-episode series follows ...

Titled "The Potential of Fasting and Diet in the Future of Medicine" Highlighting the Potential of Ketones - from Fasting, the Ketogenic diet and Pharmaceuticals - to Address Neurological Disease and ...

Tickets on Sale Now This show looks at behavior over time. It’s about how warning signs get minimized, how escalation unfolds in real life, and what we can learn when we stop relying on myths and ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...

Viridian Therapeutics develops monoclonal antibody therapies targeting rare diseases, with a focus on thyroid eye disease treatments.

Astellas is aiding Vir Biotechnology’s oncology pivot with a $1.7 billion global collaboration focused on a potential best-in-class T-cell engager (TCE) for prostate cancer. Under the leadership of ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...